Concurrently, S&P raised its underlying rating on Freeman Health’s series 1999B and 1999C bonds to “A” from “A-.”
“We raised the rating based on Freeman’s credit quality, given its steady balance sheet improvement and robust operating performance exhibited in recent years,” said S&P credit analyst Patrick Zagar.
S&P also acknowledged Freeman Health System’s light cash on hand levels.
The outlook is stable.
More articles on healthcare finance:
UCLA Health to establish health sciences learning center with $20M gift
7 latest hospital credit downgrades
10 hospitals seeking RCM talent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
